• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺实性乳头状癌中 INSM1 的免疫染色。

INSM1 immunostaining in solid papillary carcinoma of the breast.

机构信息

Department of Pathology and Experimental Medicine, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan.

Clinical Education Center, Kyushu University Hospital, Fukuoka, Japan.

出版信息

Pathol Int. 2021 Jan;71(1):51-59. doi: 10.1111/pin.13043. Epub 2020 Nov 6.

DOI:10.1111/pin.13043
PMID:33156579
Abstract

Solid papillary carcinoma (SPC) is a histological subtype of breast carcinomas. At least 50% of SPC show neuroendocrine differentiation. Insulinoma-associated protein 1 (INSM1) is a transcription factor now employed as a useful neuroendocrine marker. It is suppressed by the Notch signaling pathway in other neuroendocrine tumors. However, the usefulness of INSM1 as a neuroendocrine marker and the relationships between INSM1 and NOTCH receptors in SPC of the breast currently remain unclear. To clarify the usefulness of INSM1 as a neuroendocrine marker and the relationships between INSM1 and NOTCH receptors in SPC, we performed immunohistochemistry using 19 tissue specimens of SPC of the breast. We complementarily analyzed public RNA sequencing data on breast carcinomas. Immunohistochemical examinations revealed that the staining intensity of INSM1 was significantly higher in the neuroendocrine group than in the non-neuroendocrine group. Positive correlations were observed between INSM1 and synaptophysin (SYP), or chromogranin-A (CHGA). In all cases, NOTCH 2 and 3 were positive, while NOTCH 1 and 4 were negative. According to public RNA data analyses, there were positive correlations between INSM1 and SYP, or CHGA, and negative correlations between INSM1 and NOTCH1-3. INSM1 is useful as a diagnostic marker for SPC with neuroendocrine differentiation in the breast.

摘要

实性乳头状癌(SPC)是乳腺癌的一种组织学亚型。至少有 50%的 SPC 显示神经内分泌分化。胰岛素瘤相关蛋白 1(INSM1)是一种转录因子,现在被用作有用的神经内分泌标志物。在其他神经内分泌肿瘤中,它被 Notch 信号通路抑制。然而,INSM1 作为神经内分泌标志物的用途以及 INSM1 和 NOTCH 受体在乳腺 SPC 中的关系目前仍不清楚。为了阐明 INSM1 作为神经内分泌标志物的用途以及 INSM1 和 NOTCH 受体在乳腺 SPC 中的关系,我们使用 19 个乳腺 SPC 组织标本进行了免疫组织化学检查。我们还对乳腺癌的公共 RNA 测序数据进行了补充分析。免疫组织化学检查显示,INSM1 在神经内分泌组中的染色强度明显高于非神经内分泌组。INSM1 与突触素(SYP)或嗜铬粒蛋白 A(CHGA)之间存在正相关。在所有病例中,NOTCH2 和 3 均为阳性,而 NOTCH1 和 4 均为阴性。根据公共 RNA 数据分析,INSM1 与 SYP 或 CHGA 之间存在正相关,与 NOTCH1-3 之间存在负相关。INSM1 是乳腺具有神经内分泌分化的 SPC 的有用诊断标志物。

相似文献

1
INSM1 immunostaining in solid papillary carcinoma of the breast.乳腺实性乳头状癌中 INSM1 的免疫染色。
Pathol Int. 2021 Jan;71(1):51-59. doi: 10.1111/pin.13043. Epub 2020 Nov 6.
2
Nuclear Insulinoma-Associated Protein 1 Expression as a Marker of Neuroendocrine Differentiation in Neoplasms of the Breast.核胰岛素瘤相关蛋白 1 表达作为乳腺肿瘤神经内分泌分化的标志物。
Int J Surg Pathol. 2021 Aug;29(5):496-502. doi: 10.1177/1066896920985938. Epub 2021 Jan 9.
3
A morphological and immunohistochemical study of ductal carcinoma in situ, invasive breast carcinoma of no special type, and mucinous carcinoma of the breast in comparison with solid papillary carcinoma regarding neuroendocrine marker expression.导管原位癌、非特殊型浸润性乳腺癌和黏液癌与实性乳头状癌的形态学和免疫组织化学研究:神经内分泌标志物表达的比较。
Virchows Arch. 2024 Sep;485(3):547-555. doi: 10.1007/s00428-024-03857-x. Epub 2024 Jul 3.
4
INSM1 is a novel prognostic neuroendocrine marker for luminal B breast cancer.INSM1是一种用于管腔B型乳腺癌的新型预后神经内分泌标志物。
Pathology. 2021 Feb;53(2):170-178. doi: 10.1016/j.pathol.2020.07.004. Epub 2020 Sep 17.
5
Expression of novel neuroendocrine marker insulinoma-associated protein 1 (INSM1) in genitourinary high-grade neuroendocrine carcinomas: An immunohistochemical study with specificity analysis and comparison to chromogranin, synaptophysin, and CD56.表达新型神经内分泌标志物胰岛素瘤相关蛋白 1(INSM1)在泌尿生殖系统高级别神经内分泌癌中的研究:免疫组织化学特异性分析,并与嗜铬粒蛋白、突触素和 CD56 的比较。
Pathol Res Pract. 2020 Jun;216(6):152993. doi: 10.1016/j.prp.2020.152993. Epub 2020 Apr 26.
6
Immunohistochemical analyses of the expression profiles of INSM1, ATRX, DAXX and DLL3 in solid papillary carcinomas of the breast.乳腺实性乳头状癌中INSM1、ATRX、DAXX和DLL3表达谱的免疫组织化学分析
Oncol Lett. 2022 Apr;23(4):137. doi: 10.3892/ol.2022.13257. Epub 2022 Mar 1.
7
Insulinoma-associated protein 1 (INSM1) is a sensitive and highly specific marker of neuroendocrine differentiation in primary lung neoplasms: an immunohistochemical study of 345 cases, including 292 whole-tissue sections.胰岛素瘤相关蛋白 1(INSM1)是原发性肺肿瘤神经内分泌分化的一个敏感且高度特异的标志物:345 例病例的免疫组化研究,包括 292 例全组织切片。
Mod Pathol. 2019 Jan;32(1):100-109. doi: 10.1038/s41379-018-0122-7. Epub 2018 Aug 28.
8
INSM1 Is Less Sensitive But More Specific Than Synaptophysin in Gynecologic High-grade Neuroendocrine Carcinomas: An Immunohistochemical Study of 75 Cases With Specificity Test and Literature Review.INSM1 在妇科高级别神经内分泌癌中的敏感性低于突触素,但特异性更高:75 例病例的免疫组织化学研究及文献复习。
Am J Surg Pathol. 2021 Feb 1;45(2):147-159. doi: 10.1097/PAS.0000000000001641.
9
Expression of Insulinoma-Associated Protein 1 (INSM1) and Orthopedia Homeobox (OTP) in Tumors with Neuroendocrine Differentiation at Rare Sites.罕见部位神经内分泌分化肿瘤中胰岛素瘤相关蛋白 1(INSM1)和同源盒蛋白(OTP)的表达。
Endocr Pathol. 2019 Mar;30(1):35-42. doi: 10.1007/s12022-018-9559-y.
10
Insulinoma-associated protein 1 (INSM1) expression in breast carcinomas with neuroendocrine morphologies: application and future prospective.胰岛素瘤相关蛋白 1(INSM1)在具有神经内分泌形态的乳腺癌中的表达:应用及未来展望。
Virchows Arch. 2021 Jul;479(1):191-194. doi: 10.1007/s00428-020-02935-0. Epub 2020 Oct 6.

引用本文的文献

1
INSM1 promotes breast carcinogenesis by regulating C-MYC.INSM1通过调控C-MYC促进乳腺癌发生。
Am J Cancer Res. 2023 Aug 15;13(8):3500-3516. eCollection 2023.
2
Expression of novel neuroendocrine markers in breast carcinomas: a study of INSM1, ASCL1, and POU2F3.在乳腺癌中表达新型神经内分泌标志物:INSM1、ASCL1 和 POU2F3 的研究。
Hum Pathol. 2022 Sep;127:102-111. doi: 10.1016/j.humpath.2022.06.003. Epub 2022 Jun 8.
3
Immunohistochemical analyses of the expression profiles of INSM1, ATRX, DAXX and DLL3 in solid papillary carcinomas of the breast.
乳腺实性乳头状癌中INSM1、ATRX、DAXX和DLL3表达谱的免疫组织化学分析
Oncol Lett. 2022 Apr;23(4):137. doi: 10.3892/ol.2022.13257. Epub 2022 Mar 1.
4
INSM1, a Novel Biomarker for Detection of Neuroendocrine Neoplasms: Cytopathologists' View.INSM1:一种用于检测神经内分泌肿瘤的新型生物标志物——细胞病理学家的观点
Diagnostics (Basel). 2021 Nov 23;11(12):2172. doi: 10.3390/diagnostics11122172.
5
Syntaxin-1 and Insulinoma-Associated Protein 1 Expression in Breast Neoplasms with Neuroendocrine Features.突触结合蛋白 1 和胰岛素瘤相关蛋白 1 在具有神经内分泌特征的乳腺肿瘤中的表达。
Pathol Oncol Res. 2021 Oct 26;27:1610039. doi: 10.3389/pore.2021.1610039. eCollection 2021.